The Valley Desk

NCT01892345 · Interventional trial

A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)

Overall registry status Terminated

Phase 3

Conditions Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov